US FDA denies emergency use approval for Covaxin

New Delhi, June 11 (IANS) The US Food and Drug administration has denied approval for emergency use of Covaxin, developed by Hyderabad-based Bharat Biotech, and has asked for additional data, biophar...

Become a proud member of 1947.com to access this content.